Daily Care News for June 14, 2023
advertisement
- Continuous Glucose Monitoring Impact and Implications of Real-World Evidence: Past, Present, and Future
- Insulin Secretion Capacity as a Crucial Feature to Distinguish Type 1 From Type 2 Diabetes and to Indicate the Need for Insulin Therapy – A Critical Discussion of the ADA/EASD Consensus Statement on the Management of Type 1 Diabetes in Adults
- One Size Fits All Versus Individualized Medicine in Type 1 Diabetes Management
- Continuous Glucose Monitoring Use in Older Adults for Optimal Diabetes Management
- Advancements in Diabetes Technology Are Outpacing the Evidence
- Practical Application of Continuous Glucose Monitoring in Clinical Practice: Case Studies
- An Overview of Diet and Physical Activity for Healthy Weight in Adolescents and Young Adults with Type 1 Diabetes: Lessons Learned from the ACT1ON Consortium
- Efficacy of combination therapy with GABA, a DPP-4i and a PPI as an adjunct to insulin therapy in patients with type 1 diabetes
- The Type 1 Diabetes and EXercise Initiative (T1DEXI): Predicting hypoglycemia risk during exercise for participants with type 1 diabetes using repeated measures random forest
- The changing landscape of automated insulin delivery in the management of type 1 diabetes
- Residual insulin secretion in individuals with type 1 diabetes in Finland: longitudinal and cross-sectional analyses
- Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets
